Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate.

Self-resolving Epstein-Barr virus (EBV)-associated lymphomas have become more common with the use of immunosuppressive agents in both transplant patients and patients with connective tissue disorders. Immunosuppressive agents are often used for control of dermatomyositis, but their use has not been linked to subsequent malignancy. We present a 46-year-old woman with dermatomyositis, who developed an EBV-associated B-cell lymphoma of the brain while on oral methotrexate, mycophenolate mofetil and low-dose prednisone. The patient's lymphoma gradually resolved "spontaneously" upon discontinuation of the methotrexate and mycophenolate mofetil. The potential for EBV-associated B-cell lymphoma to self-resolve should be recognized by the clinician in order to prevent unnecessary and potentially toxic treatments including radiation therapy or multi-drug chemotherapy.
AuthorsMark A Waldman, Jeffrey P Callen
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 51 Issue 2 Suppl Pg. S124-30 (Aug 2004) ISSN: 1097-6787 [Electronic] United States
PMID15280831 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Immunosuppressive Agents
  • mycophenolate mofetil
  • Mycophenolic Acid
  • Prednisone
  • Methotrexate
  • Biopsy
  • Brain Neoplasms (diagnosis, etiology, therapy)
  • Burkitt Lymphoma (diagnosis, etiology, therapy)
  • Dermatomyositis (complications, drug therapy)
  • Humans
  • Immunosuppressive Agents (administration & dosage, adverse effects)
  • Magnetic Resonance Imaging
  • Male
  • Methotrexate (administration & dosage, adverse effects)
  • Middle Aged
  • Mycophenolic Acid (administration & dosage, adverse effects, analogs & derivatives)
  • Prednisone (administration & dosage)
  • Remission Induction
  • Withholding Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: